News & Events

“The current legislation on GMOs [genetically modified organisms], adopted in 2001, is not suitable for the new genomic techniques (NTG),” says the long-awaited study published by the European Commission (EC) at the request of the Council of the European Union (EU). O document led the EC to announce which will “initiate a broad and open consultation process to discuss the design of a new legal framework for these biotechnologies”.

“The study shows that NTG, which are techniques for altering the genome of an organism, have the potential to contribute to a more sustainable food system within the framework of the objectives of the European Green Deal and Farm to Fork Strategy“, says the EC statement. “With consumer and environmental safety as the guiding principle, the time has come to establish an open dialogue with citizens, Member States and the European Parliament in order to decide together on the way forward for the use of these biotechnologies in the EU,” stresses Stella Kyriakides, Commissioner for Health and Food Safety.

The report identifies limitations to the legislation's ability to keep up with scientific developments, causing implementation challenges and illegal uncertainties, which need to be resolved. It recognizes that it may not be justifiable to apply different levels of regulatory oversight to products with similar degrees of risk, as in the case of conventionally improved plants and those obtained from certain NTGs.

“Future regulatory actions will need to address the knowledge gaps and limitations identified in this study.” In addition, “a greater effort should be made to inform and involve the public regarding NGTs, and to assess their opinions,” admits the EC.

Entitled ‘Study on the status of new genomic techniques under Union law and in light of the Court of Justice ruling in Case C-528/16’, the study examines the current state of NTG, “taking into account the ‘state of the art’ of knowledge and the views of EU countries and stakeholders”. The Council of the EU requested this state of play on NTG under European law (Directive 2001/18/EC, Regulation (EC) 1829/2003, Directive 2009/41/EC e Regulation (EC) 1830/2003), in the light of the judgment of the Court of Justice in Case C-528/16.

Image by Congerdesign | Pixabay

“The current GMO legislation, adopted in 2001, is not fit for purpose for New Genomic Techniques (NGTs)”, says the awaited study published by the European Commission (EC), at the request of the EU Council. The document prompted the EC to announce the start of a “wide and open consultation process to discuss the design of a new legal framework for these biotechnologies”.

“The study shows that NGTs, which are techniques to alter the genome of an organism, have the potential to contribute to a more sustainable food system as part of the objectives of the European Green Deal and the Farm to Fork Strategy”, states the EC in the related press release. “With the safety of consumers and the environment as the guiding principle, now is the moment to have an open dialogue with citizens, Member States and the European Parliament to jointly decide the way forward for the use of these biotechnologies in the EU”, emphasizes Stella Kyriakides, Commissioner for Health and Food Safety.

The study identifies limitations to the capacity of legislation to keep pace with scientific developments, causing implementation challenges and legal uncertainties, which need to be addressed. It recognizes it may not be justified to apply different levels of regulatory oversight to similar products with similar levels of risk, as is the case for plants conventionally bred and obtained from certain NGTs.

“Future policy action would need to address the knowledge gaps and limitations identified in this study”. Furthermore, “importantly, more effort should be made to inform and engage with the public on NGTs and assess their views”, admits the EC.

Entitled ‘Study on the status of new genomic techniques under Union law and in light of the Court of Justice ruling in Case C-528/16’, the report examines the status of NGTs “taking into account the state of the art knowledge and the views of the EU countries and stakeholders”. The Council of the European Union asked for this study, regarding the status of new genomic techniques under Union Law (Directive 2001/18/EC, Regulation (EC) 1829/2003, Directive 2009/41/EC and Regulation (EC) 1830/2003), in light of the Court of Justice's judgment in Case C-528/16.

Image by Congerdesign, from Pixabay